Related Experiment Video
Updated: Jun 23, 2025

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Exploiting temporal aspects of cancer immunotherapy
Rachael M Zemek1,2, Valsamo Anagnostou3, Inês Pires da Silva4,5,6,7
1Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
Optimizing cancer treatment requires understanding the time-sensitive immune responses to immunotherapy and other therapies. Combining treatments strategically based on these dynamic changes can improve patient outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Therapeutics
Background:
- Effective anti-tumour immune responses are often transient and time-dependent.
- Immune checkpoint therapy (ICT) shows efficacy in some cancers, but many patients lack benefit.
- Understanding dynamic immunological changes in the tumour microenvironment is crucial for combination therapies.
Purpose of the Study:
- To analyze the temporal dynamics of immune responses during ICT.
- To overlay ICT response dynamics with responses to surgery, radiotherapy, chemotherapy, and targeted therapies.
- To propose time-conscious combination strategies for enhanced cancer treatment.
Main Methods:
- Reviewing recent studies on dynamic cellular and molecular changes during ICT.
- Overlaying temporal response data from ICT with other cancer treatment modalities.
- Analyzing time-dependent interactions between different therapeutic approaches.
Main Results:
- Identified transient and time-dependent immunological mechanisms in anti-tumour responses.
- Highlighted the need to consider temporal dynamics when combining ICT with other treatments.
- Demonstrated the potential for time-conscious combination therapies to improve outcomes.
Conclusions:
- Timing is critical for maximizing the effectiveness of immunotherapy-induced anti-tumour responses.
- Integrating temporal insights into combination cancer treatment strategies is essential.
- Time-conscious combination therapies hold promise for improving efficacy across various cancer types.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

